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Abstract
Purpose To analyze the effect of riboflavin UV-A illumination on mRNA and protein expression of healthy (HCFs) and keratoconus
human corneal fibroblasts (KC-HCFs), concerning the inflammatory markers NF-κB, iNOS, IL-6, and collagen 1 and 5 (Col 1/Col 5).
Methods Keratocytes were isolated from healthy (n = 3) and keratoconus (KC) corneas (n = 3) and were cultivated in basal medium
with 5% fetal calf serum, which resulted in their transformation into human corneal fibroblasts (HCFs/KC-HCFs). Cells underwent
0.1% riboflavin UV-A illumination for 250 s (CXL). NF-κB, iNOS, IL-6, Col 1, and Col 5 expression was investigated by qPCR and
Western blot analysis. IL-6 concentration of the cell culture supernatant and cell lysate was determined by ELISA.
Results In untreated KC-HCFs, NF-κB (p = 0.0002), iNOS (p = 0.0019), Col 1 (p = 0.0286), and Col 5 (p = 0.0054) mRNA
expression was higher and IL-6 expression was lower (p = 0.0057), than in healthy controls. In HCFs, CXL led to an increased
NF-κB (p = 0.0286) and IL-6 (p = 0.0057) mRNA expression. The IL-6 concentration in the cell culture supernatant was
increased in HCFs (p = 0.0485) and KC-HCFs (p = 0.0485) after CXL. CXL increased intracellular IL-6 concentration only
in KC-HCFs (p = 0.0357). In the HCF group (p = 0.0286), an increased Col 1 mRNA expression after CXL could be observed.
Conclusion Our study confirmed altered gene expression in untreated KC-HCFs compared to untreated HCFs. Riboflavin UV-A
illumination affected gene expression only in HCFs. Increased IL-6 concentration in the cell culture supernatant and cell lysate
indicate a secondary inflammatory response of HCFs and KC-HCFs to riboflavin UV-A illumination.
Key messages:
Untreated KC-HCFs showed an altered expression of genes linked to inflammation (NF-  B, iNOS, IL-6) and
increased mRNA expression of the collagens (Col 1 and 5) in contrast to untreated HCFs.
CXL resulted in an increased gene expression only in HCFs (NF-  B, IL-6, Col 1), whereas in KC-HCFs, none of 
the investigated genes showed expression changes after this treatment.
Increased IL-6 concentration in the cell cultures upernatant of HCFs and KC-HCFs and an increased intracellular
IL-6 concentration in KC-HCFs indicate an inflammatory response after CXL.
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Introduction
Keratoconus (KC) is a bilateral, progressive ectatic cor-
neal disease, which results in a cone-shaped protrusion
of the corneal tissue due to the thinning of the corneal
stroma. These morphological changes are associated with
reduced visual acuity, progressive myopia, and irregular
astigmatism. As part of the progressive stromal thinning
in advanced KC, the rupture of Descemet’s membrane
may cause an acute hydrops. This stromal edema subse-
quently results in corneal scarring, which makes pene-
trating keratoplasty in most cases necessary in order to
improve visual acuity [1].
In general, an annual incidence of 2/100,000 and a preva-
lence of 54.5/100,000 is assumed [2]. These data are based on
a long-term study from 1935 to 1982 and may be outdated due
to progress in diagnostics. A recent study indicates that the
annual incidence (13.3/100,000) and the prevalence (265/
100,000) could be 5-fold higher than previously reported
[3]. Although KC is known to affect all ethnic groups, its
development shows geographical variability with a higher in-
cidence among the Asian population [4].
The etiology of KC has not been clarified so far, but a
complex, multifactorial pathogenesis is assumed. In most
cases, KC occurs as an isolated disease without any evidence
of underlying concomitant diseases. KC shows a higher famil-
ial incidence, which could be an indicator of a genetic predis-
position. Biochemical alterations associated with increased
proteolytic activity are discussed to be responsible for the
degradation of corneal structural components resulting in the
biomechanical weakening of the cornea. It is also assumed
that a different distribution and lower number of stromal la-
mellae in KC is associated with reduced corneal rigidity and
thinning, compared to normal corneas. Besides, KC is more
frequent in Down syndrome, Leber’s congenital amaurosis,
Ehlers-Danlos syndrome, and osteogenesis imperfecta [5].
Although KC is classified in the common literature as a
non-inflammatory disease, there are data referring to potential
underlying inflammatory components. In a previous study of
our research group, increased nuclear factor kappa B p65
(NF-κB) mRNA and protein expression, and an increased
inducible NO synthase (iNOS) mRNA expression could be
verified in human keratoconus fibroblasts (KC-HCFs), com-
pared to healthy controls, which refers to corneal inflamma-
tion in KC [6]. In addition, an increased interleukin-6 (IL-6),
tumor necrosis factor-α (TNF-α), and matrix metalloprotease-
9 (MMP-9) concentration could be measured in tear fluid of
KC patients, and a higher concentration of these proteins was
associatedwith a more severe form of KC [7]. Besides, several
studies have demonstrated increased oxidative stress and al-
tered metabolism in KC stromal cells [8, 9].
The healthy corneal stroma is rich in collagen 1A1 (Col 1) and
contains a relatively large amount of type 5A1 collagen (Col 5).
Corneal collagen fibrils consist of type I collagen molecules that
are integrated into heterotypic fibrils together with type 5 colla-
gen. These interactions ensure the proper organization of the
collagen lamellae and regulate the diameter of the collagen fibrils
to maintain corneal transparency [10]. It has been shown that KC
is associatedwith altered collagen fibrillar diameter, alterations in
collagen distribution, and changes in fibril orientation within the
corneal stroma [11, 12].
Conservative and surgical KC treatment options depend on
the progression of the disease. In the early stages, refractive
changes can be corrected using spectacles or contact lenses.
Minimally invasive surgical treatment options include corneal
collagen cross-linking (CXL) and the implantation of
intracorneal ring segments, using these two surgical treatment
options either separately or in combination. In advanced
stages, either lamellar or penetrating keratoplasty could be
necessary [13].
The aim of CXL is to increase the stiffness of the cor-
neal tissue by forming further bonds between the collagen
fibrils. Therefore, the simultaneous use of riboflavin (vita-
min B2) as a photosensitizer and a 370-nm wavelength
UV-A light leads to cross-links between the collagen fi-
brils due to a photochemical reaction, resulting in stabili-
zation of the current state [14].
Riboflavin is excited by absorbing energy of the UV-A
light (singlet riboflavin), and it is converted into a triplet state.
Type I and type II reactions can be distinguished. For the type
II reaction, oxygen is required to form singlet oxygen, an
oxygen radical, which react with the carbonyl group of the
collagen [14]. The type I reaction takes place after that the
oxygen is exhausted, in which the excited riboflavin (triplet
state) is transferring a hydrogen atom or electron to biomole-
cules such as lipids, proteins, and nucleic acids or generates
reactive oxygen species (ROS) like superoxide anion, hydrox-
yl radical, or hydrogen peroxide [15]. As a consequence of
these reactions, the collagen fibrils are cross-linked, and thus,
the current stage of the disease is stabilized.
The first clinical results of CXL were published in 2003 by
Wollensak et al. to conclude that the progression of KC could
be slowed down [16].
Nowadays, CXL represents an important therapeutic op-
tion for KC patients, but the cellular effects are not well un-
derstood. In a previous study, we have shown that riboflavin
UV-A illumination is associated with increased apoptosis and
decreased viability of keratoconus stromal cells [17].
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In the present work, our purpose was to analyze the effects of
riboflavin UV-A illumination on mRNA and protein expression
of healthy (HCFs) and keratoconus human corneal fibroblasts
(KC-HCFs), concerning the inflammatory markers NF-κB,
iNOS, IL-6, and collagen 1 and 5 (Col 1/Col 5). As a first step,
our purpose was to investigate NF-κB, iNOS, IL-6, and Col 1/
Col 5 mRNA and protein expression differences between un-
treated healthy and KC human corneal fibroblasts. As a second
step, we aimed to investigate the inflammatory response (NF-κB,
iNOS, IL-6) related to the increased free oxygen species forma-
tion after riboflavinUV-A illumination in these cells. Thirdly, we
aimed to examinewhether a riboflavinUV-A illumination has an
impact on Col 1/Col 5 expression.
Materials and methods
Ethics approval and consent to participate
This study was performed in accordance with the Declaration
of Helsinki and was approved by the Ethics Committee of
Saarland/Germany (No. 41/18). An informed consent was ob-
tained from all participants with KC, before keratoplasty was
performed.
Cell culture
Three normal human corneas were obtained from the LIONS
Cornea Bank Saar-Lor-Lux, Trier/Westpfalz. Donor
corneoscleral buttons, which did not match the criteria for
transplantation (less than 1800 endothelial cells/mm2), have
been used for the experiments. In addition, central corneal
buttons with a diameter of 8.0 mm were obtained from elec-
tive penetrating keratoplasties of 3 KC patients who did not
undergo previous ocular surgery. Immediately after elective
penetrating keratoplasty, the explanted corneal buttons were
further processed for cell cultivation. The donor corneoscleral
buttons were explanted within 24 h postmortem. As these
corneas were not considered suitable for elective keratoplasty,
they were released for study purposes. Therefore, three healthy
human corneas and three corneas fromKCpatients were used for
cell cultivation. Further information on donor corneoscleral but-
tons and KC patients is provided in Tables 1 and 2.
Cell culture work was performed under sterile condi-
tions. The donor corneoscleral buttons were first rinsed in
phosphate-buffered saline (PBS) (Sigma-Aldrich, St.
Louis, USA); then, adjacent scleral parts with 2 mm of
the clear cornea were removed, and the central corneal
button was cut into pieces using a disposable surgical scal-
pel. For isolation of the keratocytes, the tissue was incu-
bated with 1.0 mg/ml collagenase A (Hoffmann-La Roche,
Basel, Switzerland) together with cell culture medium
consisting of Dulbecco’s modified Eagle’s medium
(DMEM/F12) (Thermo Fisher Scientific, Waltham, MA,
USA), 5% fetal calf serum (FCS) (Thermo Fisher
Scientific, Waltham, MA, USA), and 1% penicillin-
streptomycin (P/S) (Sigma-Aldrich, St. Louis, USA) for
24 h at 37 °C, which is a common standard procedure for
fibroblast cell culture work. The above-mentioned mixture
(DMEM/F12, FCS, P/S) is defined in the following text as
cell culture medium. The digested tissue and cells were
centrifuged at 800g for 7 min, and the supernatant was
discarded. After resuspending the cell pellet with 1 ml
PBS, the cell suspension was seeded in a 75-cm2 cell cul-
ture flask containing 13 ml of cell culture medium, which
was changed every third or fourth day until the cells
reached confluence. Cultivation was performed in an incu-
bator at 37 °C with 95% relative humidity and 5% CO2
atmosphere. The confluent cell culture was harvested with
trypsin EDTA (Sigma-Aldrich, St. Louis, USA) and was
split into several 75-cm2 cell culture flasks. The influence
of the FCS resulted in a differentiation of the keratocytes
into fibroblasts. Therefore, we specify them further on as
“human corneal fibroblasts” (HCFs) and “keratoconus hu-
man corneal fibroblasts” (KC-HCFs). Experiments were
performed using passages three to eight of the cells.
Riboflavin UV-A illumination of HCFs
and KC-HCFs
The cell culture medium was changed 24 h before starting the
experiments. Riboflavin (Sigma-Aldrich, St. Louis, USA)was
diluted with cell culture medium to a concentration of 0.1%,
was protected from light, and was stored at 4 °C for the ex-
periments (further on “riboflavin solution”).
Table 1 Descriptive data of donor corneoscleral buttons
Donor age (years) Gender Side Cause of death Exclusion from corneal transplantation
HCF 1 81 Female Right Intracranial hemorrhage < 1800 endothelial cells/mm2
HCF 2 90 Male Right Bronchial carcinoma Used for Descemet membrane endothelial
keratoplasty tissue preparation
HCF 3 69 Male Left Intracranial hemorrhage < 1800 endothelial cells/mm2
Graefes Arch Clin Exp Ophthalmol
As a first step, the cell culture supernatant was removed, and
either 5 ml cell culture medium or 5 ml of the riboflavin solution
was pipetted into the cell culture flask under the sterile bench.
Thereafter, the cell culture was quickly placed in the dark or was
illuminated with 375-nm UV-A light for 250 s (2 J/cm2) in an
illumination box. After the immediate removal of the cell culture
medium or the riboflavin solution, the flask was rinsed twice
with 10 ml PBS.We added to each cell culture 10 ml cell culture
medium, and cells were cultured for 24 h or 48 h at 37 °C before
measurements. In order to determine the IL-6 concentration in
the cell culture supernatant, 1.5 ml cell culture supernatant was
collected from each flask before harvesting of the cells (24 h or
48 h after the experiment) and was stored at − 80 °C.
Then, the cells were harvested with trypsin EDTA and
were stored at − 80 °C until further use.
RNA isolation and cDNA synthesis
RNA was isolated using the RNA Purification Plus Micro Kit
(Norgen Biotek Corp., Thorold, Canada), following the instruc-
tions provided by the manufacturer. RNA quantity was deter-
mined using a UV/VIS spectrophotometer (Analytik Jena AG,
Jena, Germany), and the eluted RNA was stored at − 80 °C for
further use.
The cDNA synthesis was performed using the OneTaq RT-
PCR Kit (New England BioLabs, Frankfurt a. M., Germany)
according to the instructions provided for the Kit. For cDNA
synthesis, 1 μg of total RNA was used as template for all
samples. The synthesized cDNA was stored at − 20 °C for
further use.
Quantitative PCR
The reaction mix (total volume: 9 μl) for quantitative PCR
(qPCR) consisted of 1 μl of the specific primer solution,
5 μl SYBR Green Mix (Qiagen N.V., Venlo, Netherlands),
and 3 μl nuclease-free water. The qPCR reactions were per-
formed using the QuantStudio 5 real-time PCR system
(Thermo Fisher Scientific, Waltham, MA, USA). Samples
were run in 9 μl volume using 1.5 μl cDNA according to
the manufacturer’s instructions. The amplification conditions
(40 cycles) were 95 °C for 10 s, 60 °C for 30 s, and 95 °C for
15 s. All samples were measured in duplicate. Values were
normalized to Tata-binding protein (TBP) expression levels as
endogenous control gene, using the ΔΔCT method. The fold
change (2ΔΔCT-value) was used for the statistical analysis. A list
of primers used for qPCR is summarized in Table 3. Normal
HCFs (incubated in the dark with cell culture medium for 250
s) were used as controls (fold change = 1). Gene expression
was measured for predetermined time points (Table 4), which
have been chosen according to previous measurement series
of our research group [18].
Protein quantification and Western blot analysis
Cells were lysed in RIPA buffer (Thermo Fisher Scientific,
Waltham, MA, USA) 48 h after the experiments, and pro-
tein concentration was determined using the Pierce™ BCA
Protein Assay Kit (Thermo Fisher Scientific, Waltham,
MA, USA). The measurement was performed using the
Tecan Infinite F50 Absorbance Microplate Reader (Tecan
Table 2 Keratoconus patient characteristics corresponding to the primary cell cultures
Patient age (years) Gender Side Keratoconus grading
(ABCD system, Belin)
Co-morbidities Corneal explant size (mm) Time from
explantation to
cell cultivation (h)
KC-HCF 1 51 Male Right A4/B4/C4/D4+ Arterial hypertension 8.0 < 12
KC-HCF 2 31 Male Left A4/B4/C4/D4+ Healthy 8.0 < 12
KC-HCF 3 36 Female Right A0/B2/C4/D2+ Healthy 8.0 < 12
Table 3 Primer pairs used for qPCR
Primer Primer sequence or QIAGEN catalog number Manufacturer (company, city, country)
Collagen 1A1 (Col 1) QT00037793 Qiagen N.V., Venlo, Netherlands
Collagen 5A1 (Col 5) QT00044527 Qiagen N.V., Venlo, Netherlands
Inducible NO synthase (iNOS) CTGGCAAGCCCAAGGTCTAT
GGAGGCTCCGATCAATCCAG
Eurofins Genomics Germany GmbH, Ebersberg, Germany
Interleukin-6 (IL-6) QT00083720 Qiagen N.V., Venlo, Netherlands
Nuclear factor kappa B p65 (NF-κB) QT02324308 Qiagen N.V., Venlo, Netherlands
Tata-binding protein (TBP) QT00000721 Qiagen N.V., Venlo, Netherlands
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Group AG, Männedorf, Switzerland) with 560-nm wave-
length. Bovine serum albumin (BSA) was used as a stan-
dard. The measurements were performed in duplicate. For
Western blot analysis, samples with 20 μg total protein
were boiled in a sample buffer for 5 min at 95 °C and were
loaded on a precast 4–12% NuPage™ Bis-Tris SDS Gel
(Invitrogen, Waltham, MA, USA). The first well was load-
ed with 3 μl Precision Plus Protein™ Dual Color Standard
(Bio-Rad Laboratories, Hercules, USA) to determine the
molecular weight. NuPAGE™ MOPS SDS Running
Buffer (20×) (Thermo Fisher Scientific, Waltham, MA,
USA) was used as an electrophoresis buffer. After protein
separation, semi-dry blotting on a nitrocellulose membrane
was performed using the Trans-Blot Turbo Transfer System
(Bio-Rad Laboratories, Hercules, USA), according to the
pre-installed blotting protocol for high molecular weight
proteins. The membrane was washed three times with
15 ml Western Froxx washing solution (BioFroxx GmbH,
Einhausen, Germany) for 5 min, which was followed by
primary antibody incubation at 4 °C. A list of antibodies
used for Western blot analysis is summarized in Table 5.
The primary antibodies were diluted in a combined
blocking and secondary antibody solution (WesternFroxx
anti-Mouse HRP/anti-Rabbit HRP; BioFroxx GmbH,
Einhausen, Germany). Calnexin was used as a reference
protein. After the removal of the antibody solution, the
membrane was incubated with 15 ml washing solution three
times. Protein band detection was performed with the
Western Lightning Plus Chemiluminescence Reagent
(PerkinElmer Inc., Waltham, MA, USA). The chemilumi-
nescence signal was detected using the ImageQuant LAS
400 (GE Healthcare, Chicago, USA). Thereafter, the mem-
brane stripping was performed using the Western Froxx
str ipping solut ion (BioFroxx GmbH, Einhausen,
Germany).
ELISA
Enzyme-linked immunosorbent assay (ELISA) was used to
determine the IL-6 concentration of the cell culture superna-
tant (24 h and 48 h after experiments) and cell lysate (48 h
after experiments).
The detection procedure was based on the sandwich
ELISA technique’s principle using the Human IL-6
Quantikine ELISA Kit (R&D Systems, Minneapolis,
USA), according to the provided instructions, at room
temperature. Measurements were performed in duplicate
with 100 μl of the antigen-containing sample solution
(cell culture supernatant or lysate). The quantitative de-
tection of the IL-6 concentration was measured by a
Tecan Infinite F50 Absorbance Microplate Reader using
a standard provided curve. Measured IL-6 concentra-
tions were divided by the total protein concentrations
to obtain the IL-6 concentration in picogram per milli-
gram protein. The quotient (pg IL-6/mg protein) was
used for further statistical analysis.
Table 4 The examined gene




Gen Time points of gene expression
measurement after riboflavin UV-A illumination
Inducible NO synthase (iNOS) 48 h
Interleukin-6 (IL-6) 24 h + 48 h
Collagen 1A1 (Col 1) 24 h
Collagen 5A1 (Col 5) 24 h
Nuclear factor kappa B p65 (NF-κB) 24 h
Tata-binding protein (TBP) 24 h + 48 h
Table 5 Catalog number,
manufacturer/distributor, and




Manufacturer (company, city, country) Dilution
Calnexin (anti-rabbit) ADI-SPA-865 Enzo Life Sciences GmbH, Lörrach,
Germany
1:1000
Collagen 1A1 (anti-rabbit) 84336 Cell Signaling Technology, MA, USA 1:1000
Collagen 5A1 (anti-rabbit) ab7046 Abcam, Cambridge, UK 1:5000
Inducible NO synthase (anti-rabbit) ab3523 Abcam, Cambridge, UK 1:1000
Nuclear factor kappa B p65
(anti-rabbit)
8242 Cell Signaling Technology, MA, USA 1:1000
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Statistical analysis
GraphPad Prism 7.04 was used for the statistical analysis and
for creating the diagrams. All data were expressed as mean ±
SEM. Difference between groups was determined using




Gene expression in untreated HCFs and KC-HCFs
NF-κB and iNOS mRNA expression was higher (p = 0.0002;
p = 0.0019) and IL-6 (p = 0.0057) mRNA expression was
lower in untreated KC-HCFs than in untreated healthy con-
trols (Fig. 1). Col 1 and Col 5 mRNA expression was higher in
KC-HCFs than in HCFs (p = 0.0019; p = 0.0054) (Fig. 2).
Gene expression in HCFs and KC-HCFs after riboflavin UV-A
illumination
NF-κB and IL-6 mRNA expression increased (p = 0.0286;
p = 0.0286) in HCFs after 0.1% riboflavin UV-A illumina-
tion. NF-κB and iNOS mRNA expression remained un-
changed in KC-HCFs after treatment (p = 0.2788; p =
0.7457) and iNOS mRNA expression did not change
through 0.1% riboflavin UV-A illumination in HCFs or
KC-HCFs (p = 0.3143) (Fig. 1).
Col 1 mRNA expression increased in HCFs following
0.1% riboflavin UV-A illumination (p = 0.0286) and Col 5
expression remained unchanged in HCFs and KC-HCFs after
treatment (p = 0.0971; p = 0.4623) (Fig. 2).
Western blot
NF-κB (p = 0.7308), iNOS (p = 0.6282), Col 1 (p = 0.3660),
and Col 5 (p = 0.1255) protein expression did not differ be-
tween untreated HCFs and KC-HCFs. NF-κB (p = 0.9999; p =
0.9999), iNOS (p = 0.9999; p = 0.6667), Col 1 (p = 0.3660; p
= 0.5167), and Col 5 (p = 0.8571; p = 0.5714) protein expres-
sion remained unchanged in HCFs or KC-HCFs through 0.1%
riboflavin UV-A illumination (Figs. 1 and 2).
ELISA
IL-6 concentration in the cell culture supernatant did not differ
between untreated HCFs and KC-HCFs (24 h: p = 0.8785; 48
h: p = 0.0650). Twenty-four hours after treatment, IL-6 con-
centration in the cell culture supernatant did not change in
HCFs and KC-HCFs (p = 0.4970; p = 0.1333) .
Nevertheless, 48 h after 0.1% riboflavin UV-A illumination,
IL-6 concentration in the cell culture supernatant increased in
HCFs (p = 0.0485) and KC-HCFs (p = 0.0485), compared to
baseline values (Fig. 1).
In the cell lysate, IL-6 concentration did not differ between
untreated HCFs and KC-HCFs (p = 0.7922). Nevertheless, in
the cell lysate, IL-6 concentration increased in KC-HCFs 48 h
after 0.1% riboflavin UV-A illumination (p = 0.0357). In
HCFs, IL-6 concentration in the cell lysate remained un-
changed after treatment (p = 0.1667) (Fig. 1).
Discussion
Little is known about the pathogenesis of KC, but along the
reported changes in collagen metabolism [11, 12], the suspicion
of a chronic inflammatory component is increasingly coming to
the fore. Since cross-linking was first introduced by Wollensak
et al. in 2003 [16], it became an indispensable therapeutic option
for treating ectatic corneal disorders. However, the cell biological
effects after CXL were barely investigated. Therefore, in this
study, we treated corneal fibroblasts in vitro with riboflavin
UV-A illumination, to examine the impact of CXL regarding
expression changes of inflammatory markers NF-κB, iNOS,
IL-6, and collagen 1 and 5 in HCFs and KC-HCFs.
We could demonstrate changes in gene expression linked
to inflammation in untreated KC-HCFs. NF-κB is an impor-
tant modulator of many cell biological pathways through its
influence on more than 500 genes, mainly genes associated
with inflammatory responses [19]. Both iNOS and IL-6 are
influenced by NF-κB [20, 21]. Additionally, iNOS is
Fig. 1 Effect of riboflavin UV-A illumination on NF-κB, iNOS, and
IL-6 mRNA and protein expression (untreated group: white bars;
riboflavin UV-A illumination group: blue bars). NF-κB (24 h),
iNOS (48 h), and IL-6 (24 h and 48 h) gene expression was mea-
sured 24 or 48 h after riboflavin UV-A illumination. NF-κB and
iNOS protein expression analysis was performed 48 h after ribofla-
vin UV-A illumination. IL-6 concentration of the cell culture super-
natant (24 h and 48 h after treatment) and cell lysate (48 h after
treatment) was determined by ELISA. (A–D) NF-κB, iNOS, and
IL-6 quantitative mRNA analysis. Data show mean ± SEM of at least
3 independent experiments in duplicate. (E, F) Relative quantifica-
tion of NF-κB and iNOS Western blot analysis. Calnexin was used
as loading control and to calculate the relative protein expression
levels. Data show mean ± SEM of at least 3 independent experiments
in duplicate. (G–I) IL-6 concentration was determined in cell culture
supernatant and cell lysate 24 and/or 48 h after riboflavin UV-A
illumination. Measured IL-6 concentrations were divided by the total
protein concentrations, to obtain the IL-6 concentration in pg per mg
protein, these values are displayed (pg IL-6/mg protein). Data show
mean ± SEM of at least 3 independent experiments in duplicate. (J,
K) Representative NF-κB and iNOS Western blots. Significant p-
values (< 0.05) are highlighted in the diagrams
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activated by IL-1, TNF-α, and interferon-γ and leads to the
production of nitric oxygen as part of inflammatory processes
[22]. Besides elevated inflammatory markers in the tear fluid
of KC patients [7], Karamichos et al. reported an increase in
metabolites associated with oxidative stress in KC
keratocytes, which could be related to a chronic inflammatory
condition [8]. We argue that increased iNOS mRNA expres-
sion in KC-HCFs is due to underlying inflammatory processes
in KC, whichmay be induced by increased production of ROS
and other metabolic pathway changes. In another study, KC-
HCFs showed an increased ROS production, through which
these cells got more vulnerable to additional oxidative stress
than HCFs [23]. As CXL itself results in oxidative stress [14],
resulting in a secondary inflammatory reaction, we investigat-
ed its effects on HCFs and KC-HCFs. In a previous study of
our research group, we demonstrated an increased apoptotic
rate of stromal cells and reduced cell viability in KC-HCFs,
after riboflavin UV-A illumination [17], whereas in another
study, normal HCFs were less vulnerable [24]. Increased
keratocyte apoptosis after CXL could also be demonstrated
in KC corneas [25]. Myofibroblastic transformation following
CXL also differed significantly between KC and normal cor-
neal stromal cells [17, 24].
In our present study, we could demonstrate that riboflavin
UV-A illumination is associated with a significant increase in
NF-κB and IL-6 mRNA expression in HCFs, but in KC-HCFs,
no changes were detected. This could be related to an altered
NF-κB and IL-6 mRNA expression in untreated KC-HCFs
compared to untreated HCFs and may refer to an underlying
cellular stress reaction in KC-HCFs [8], with an insufficient
capacity of KC-HCFs to further increase gene expression, due
to possibly restricted regulatory mechanisms. In a recently pub-
lished study of our research group, we investigated the influ-
ence of hypoxic stress on HCFs and KC-HCF [18].
Interestingly, increased gene expression of inflammatory
markers (NF-κB and iNOS) was only observed within the
HCF group, whereas in KC-HCFs, gene expression was not
influenced through hypoxia. Increased ROS production after
riboflavin UV-A illumination, as well as hypoxia, could result
in inflammatory reactions, but further investigation is necessary
to clarify why changes in gene expression could not be mea-
sured in KC-HCFs after those specific stress stimuli.
Fig. 2 Effect of riboflavin UV-A illumination on Col 1 and Col 5 mRNA
and protein expression (untreated group: white bars; riboflavin UV-A
illumination group: blue bars). Col 1 and Col 5 mRNA expression was
measured 24 h after riboflavinUV-A illumination. The protein expression
analysis was performed 48 h after treatment. (A, B) Col 1 and Col 5
quantitative mRNA analysis. Data show mean ± SEM of at least 3
independent experiments in duplicate. (C, D) Relative quantification of
Col 1 and Col 5 Western blot analysis. Calnexin was used as loading
control and to calculate the relative protein expression levels. (E, F)
Representative Col 1 and Col 5 Western blots. Significant p values (<
0.05) were highlighted in the diagrams
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Although no IL-6 mRNA expression changes in KC-HCFs
could be measured after riboflavin UV-A illumination, IL-6
protein amount increased significantly in the cell culture su-
pernatant through riboflavin UV-A illumination in both HCFs
and KC-HCFs. However, a difference in the IL-6 concentra-
tion of the cell culture supernatant could only be observed
after 48 h, indicating that this might be a delayed reaction of
the corneal fibroblasts after riboflavin UV-A illumination,
which should be considered in future studies. Interestingly,
riboflavin UV-A illumination resulted in an increased intra-
cellular IL-6 concentration only in KC-HCFs, which was not
accompanied by altered mRNA expression. This could indi-
cate that KC-HCFs can only partially compensate the induced
stress stimulus and therefore have a significant intracellular
stress response.
In this study, corneas with advanced KC stages (Belin
KC classification) and corneal scarring were used [26].
Most interestingly, we detected an increased Col 1 and
Col 5 mRNA expression in KC-HCFs compared to
HCFs, which refers to the disturbance of the collagen me-
tabolism in KC corneas [11, 12]. In addition, the Col 1 and
Col 5 mRNA expression values have shown a larger vari-
ability in KC-HCFs than in HCFs. These variable values
were confirmed through repeat measurements. We suggest
that these differences depend on the individual patient’s
cornea and in addition, during KC progression, gene ex-
pression could also change. It is important to investigate
these results in future studies, for example, by comparing
the mRNA and protein expression of KC corneas with or
without scars or under consideration of the KC stage.
Furthermore, we investigated whether CXL is associated
with changes in collagen expression. In this study, we ob-
served increased Col 1 mRNA expression only in HCFs with-
out significant protein expression changes in HCFs or KC-
HCFs following riboflavin UV-A illumination. Another study
described a significant Col 1 and Col 5 protein expression
decrease after 0.1% riboflavin UV-A illumination in KC-
HCFs, but not in HCFs, nevertheless, using 3D cell cultures
[27]. To which extent these changes could be of cell biological
or clinical relevance must be critically analyzed.
Finally, it is necessary to mention certain limitations of our
study concerning the interpretation of the results. On the one
hand, the avascular stroma represents a nutrient-poor tissue.
Therefore, in vitro experiments are not equally applicable to
in vivo models. Our isolated keratocytes dedifferentiated into
fibroblasts during cell cultivation, using FCS, which could prob-
ably have a significant impact on gene and protein expression.
The results of the 2D culture are also not directly transferable to
the in vivo model, but give a good indication for further studies.
In addition, there is no suitable in vivo model or animal model to
studyKC. In summary, we found expression differences between
untreated and treated corneal fibroblasts, which is an important
input for future studies.
Conclusions
In this study, altered mRNA expression of the inflammatory
markers (NF-κB, iNOS, IL-6), as well as the collagens (Col 1,
Col 5), could be detected in untreated KC-HCFs. Riboflavin
UV-A illumination resulted in significant gene expression
changes only in HCFs. Increased IL-6 concentrations in the
cell culture supernatant (HCFs and KC-HCFs) and cell lysate
(KC-HCFs) indicated an inflammatory response after this
treatment. The effects of cross-linking on gene and protein
expression have rarely been investigated, and therefore, the
results of this study provide a basis for further research
projects.
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